United States · 
How much has Gila Therapeutics raised?
Gila Therapeutics has raised $356K across 1 round since 2022.
United States · Seed startup
Who invested in Gila Therapeutics
Funding summaryUpdated 26 Oct 2026
$356Kraised across 1 round since 2022, from 1 source
- Latest round
- Seed, $356KNov 2022
- Investors
- 0
The rounds
- Nov 2022Seed$356K
No investor was named in the report.
Source recordedSEC filing: $356K sold, first sale Nov 2022
Founders and team
From Gila Therapeutics's own website and the SEC filings it signed: 6 on the team.
- Richard G. HoranActing CEO & Director
- Tim BarberichDirector
- Jon FreemanExecutive Officeri
- Sangeeta KashyapExecutive Officeri
- Scott SchorerExecutive Officer, Directori
- Thomas VasicekExecutive Officeri
On the board, as filediChristopher De SouzaPraveen TyleTimothy Barberich
Also claim to have backed them
These 5 firms list Gila Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Gila Therapeutics
When did Gila Therapeutics last raise?
Gila Therapeutics's most recent round was a Seed of $356K in Nov 2022.
What was Gila Therapeutics's biggest round?
Its most recent round, $356K in Nov 2022, is also its largest on record.
What stage is Gila Therapeutics at?
Gila Therapeutics's latest named round is a Seed, in Nov 2022.
Where is Gila Therapeutics based?
Gila Therapeutics is based in the United States.
Companies like Gila Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.